$RGRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERX BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REGENERX BIOPHARMACEUTICALS INC. Get notifications about new insider transactions in REGENERX BIOPHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 20 2020 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | P | 0.45 | 10,440 | 4,698 | 10,440 | |
Oct 20 2020 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | P | 0.45 | 20,880 | 9,396 | 20,880 | |
Oct 20 2020 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | P | 0.45 | 20,880 | 9,396 | 20,880 | |
Jun 12 2020 | RGRX | REGENERX BIOPHARMA ... | Noseda Alessandro | Director | Option Exercise | A | 0.30 | 200,000 | 60,000 | 200,000 | |
Jun 12 2020 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.30 | 250,000 | 75,000 | 250,000 | |
Jun 12 2020 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.30 | 400,000 | 120,000 | 400,000 | |
Jun 12 2020 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.30 | 500,000 | 150,000 | 500,000 | |
Jun 12 2020 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | A | 0.30 | 250,000 | 75,000 | 250,000 | |
Jun 12 2020 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | A | 0.30 | 200,000 | 60,000 | 200,000 | |
Aug 28 2019 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Gift | G | 0.00 | 228,000 | 0 | 1,712,793 | 1.9 M to 1.7 M (-11.75 %) |
May 17 2019 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | A | 0.21 | 200,000 | 42,000 | 200,000 | |
May 17 2019 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.21 | 410,000 | 86,100 | 410,000 | |
May 17 2019 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.21 | 650,000 | 136,500 | 650,000 | |
May 17 2019 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.21 | 250,000 | 52,500 | 250,000 | |
May 16 2019 | RGRX | REGENERX BIOPHARMA ... | Essetifin SPA | 10% Owner | Option Exercise | J | 0.18 | 3,125,000 | 562,500 | 3,125,000 | |
May 15 2019 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | P | 0.18 | 31,250 | 5,625 | 31,250 | |
May 15 2019 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | P | 0.18 | 78,125 | 14,063 | 78,125 | |
May 15 2019 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | P | 0.18 | 15,625 | 2,813 | 15,625 | |
May 15 2019 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | P | 0.18 | 15,625 | 2,813 | 15,625 | |
Mar 01 2019 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | P | 0.18 | 78,125 | 14,063 | 78,125 | |
Mar 01 2019 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | P | 0.18 | 78,125 | 14,063 | 78,125 | |
Mar 01 2019 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | P | 0.18 | 31,250 | 5,625 | 31,250 | |
Mar 01 2019 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | P | 0.18 | 31,250 | 5,625 | 31,250 | |
Mar 01 2019 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | P | 0.18 | 15,625 | 2,813 | 15,625 | |
Mar 01 2019 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | P | 0.18 | 15,625 | 2,813 | 15,625 | |
Mar 01 2019 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | P | 0.18 | 78,125 | 14,063 | 78,125 | |
Mar 01 2019 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | P | 0.18 | 78,125 | 14,063 | 78,125 | |
Mar 01 2019 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | P | 0.18 | 15,625 | 2,813 | 15,625 | |
Mar 01 2019 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | P | 0.18 | 15,625 | 2,813 | 15,625 | |
Feb 27 2019 | RGRX | REGENERX BIOPHARMA ... | Essetifin SPA | 10% Owner | Option Exercise | J | 0.18 | 2,884,615 | 519,231 | 2,884,615 | |
Jan 08 2019 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | C | 0.06 | 208,912 | 12,535 | 0 | |
Jan 08 2019 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Buy | C | 0.06 | 208,912 | 12,535 | 1,940,793 | 1.7 M to 1.9 M (+12.06 %) |
Jan 08 2019 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | C | 0.06 | 522,280 | 31,337 | 0 | |
Jan 08 2019 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Buy | C | 0.06 | 522,280 | 31,337 | 6,524,122 | 6 M to 6.5 M (+8.70 %) |
Sep 28 2018 | RGRX | REGENERX BIOPHARMA ... | Essetifin SPA | 10% Owner | Buy | C | 0.06 | 3,133,681 | 188,021 | 34,989,080 | 31.9 M to 35 M (+9.84 %) |
Sep 13 2018 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | C | 0.06 | 104,456 | 6,267 | 0 | |
Sep 13 2018 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Buy | C | 0.06 | 104,456 | 6,267 | 104,456 | 0 to 104.5 K |
Sep 13 2018 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | C | 0.06 | 2,089,120 | 125,347 | 0 | |
Sep 13 2018 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Buy | C | 0.06 | 2,089,120 | 125,347 | 6,001,842 | 3.9 M to 6 M (+53.39 %) |
Sep 13 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | C | 0.06 | 229,803 | 13,788 | 0 | |
Sep 13 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Buy | C | 0.06 | 229,803 | 13,788 | 1,731,881 | 1.5 M to 1.7 M (+15.30 %) |
Jul 19 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.21 | 250,000 | 52,500 | 250,000 | |
Jul 19 2018 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.21 | 200,000 | 42,000 | 200,000 | |
Jul 19 2018 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.21 | 250,000 | 52,500 | 250,000 | |
Jul 19 2018 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | A | 0.21 | 200,000 | 42,000 | 325,000 | |
Jul 19 2018 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | A | 0.21 | 200,000 | 42,000 | 325,000 | |
Jul 09 2018 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | C | 0.06 | 104,456 | 6,267 | 0 | |
Jul 09 2018 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Buy | C | 0.06 | 104,456 | 6,267 | 1,637,991 | 1.5 M to 1.6 M (+6.81 %) |
Jul 09 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | C | 0.06 | 208,912 | 12,535 | 0 | |
Jul 09 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Buy | C | 0.06 | 208,912 | 12,535 | 1,502,078 | 1.3 M to 1.5 M (+16.16 %) |
Jul 09 2018 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | C | 0.06 | 1,044,560 | 62,674 | 0 | |
Jul 09 2018 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Buy | C | 0.06 | 1,044,560 | 62,674 | 3,912,722 | 2.9 M to 3.9 M (+36.42 %) |
Apr 02 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | C | 0.06 | 522,280 | 31,337 | 0 | |
Apr 02 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Buy | C | 0.06 | 522,280 | 31,337 | 1,293,166 | 770.9 K to 1.3 M (+67.75 %) |
Apr 02 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Gift | G | 0.00 | 250,000 | 0 | 770,886 | 1 M to 770.9 K (-24.49 %) |
Apr 02 2018 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | C | 0.06 | 1,044,560 | 62,674 | 0 | |
Apr 02 2018 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Buy | C | 0.06 | 1,044,560 | 62,674 | 2,868,162 | 1.8 M to 2.9 M (+57.28 %) |
Apr 02 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | C | 0.06 | 522,280 | 31,337 | 0 | |
Apr 02 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Buy | C | 0.06 | 522,280 | 31,337 | 1,293,166 | 770.9 K to 1.3 M (+67.75 %) |
Apr 02 2018 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Gift | G | 0.00 | 250,000 | 0 | 770,886 | 1 M to 770.9 K (-24.49 %) |
Apr 02 2018 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | C | 0.06 | 1,044,560 | 62,674 | 0 | |
Apr 02 2018 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Buy | C | 0.06 | 1,044,560 | 62,674 | 2,868,162 | 1.8 M to 2.9 M (+57.28 %) |
Mar 14 2018 | RGRX | REGENERX BIOPHARMA ... | Essetifin SPA | 10% Owner | Buy | P | 0.23 | 6,348,878 | 1,460,242 | 31,855,399 | 25.5 M to 31.9 M (+24.89 %) |
Mar 14 2018 | RGRX | REGENERX BIOPHARMA ... | Essetifin SPA | 10% Owner | Buy | P | 0.23 | 11,584,795 | 2,664,503 | 25,506,521 | 13.9 M to 25.5 M (+83.21 %) |
Mar 14 2018 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Sell | S | 0.23 | 11,584,795 | 2,664,503 | 0 | 11.6 M to 0 (-100.00 %) |
Mar 14 2018 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Sell | J | 0.00 | 64,575 | 0 | 11,584,795 | 11.6 M to 11.6 M (-0.55 %) |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | X | 0.15 | 66,667 | 10,000 | 0 | |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | C | 0.15 | 417,824 | 62,674 | 0 | |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Buy | X | 0.15 | 66,667 | 10,000 | 1,823,602 | 1.8 M to 1.8 M (+3.79 %) |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Buy | C | 0.15 | 417,824 | 62,674 | 1,756,935 | 1.3 M to 1.8 M (+31.20 %) |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | X | 0.15 | 20,000 | 3,000 | 0 | |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | C | 0.15 | 125,347 | 18,802 | 0 | |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Buy | X | 0.15 | 20,000 | 3,000 | 1,533,535 | 1.5 M to 1.5 M (+1.32 %) |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Buy | C | 0.15 | 125,347 | 18,802 | 1,513,535 | 1.4 M to 1.5 M (+9.03 %) |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | X | 0.15 | 46,666 | 7,000 | 0 | |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | C | 0.15 | 292,477 | 43,872 | 0 | |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Buy | X | 0.15 | 46,666 | 7,000 | 1,020,886 | 974.2 K to 1 M (+4.79 %) |
Oct 20 2017 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Buy | C | 0.15 | 292,477 | 43,872 | 974,220 | 681.7 K to 974.2 K (+42.90 %) |
Oct 17 2017 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | J | 0.15 | 266,667 | 40,000 | 0 | |
Oct 17 2017 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | C | 0.15 | 1,671,296 | 250,694 | 0 | |
Oct 17 2017 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Buy | J | 0.00 | 266,667 | 0 | 11,649,370 | 11.4 M to 11.6 M (+2.34 %) |
Oct 17 2017 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Buy | C | 0.00 | 1,671,296 | 0 | 11,382,703 | 9.7 M to 11.4 M (+17.21 %) |
Sep 06 2017 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.28 | 150,000 | 42,000 | 150,000 | |
Sep 06 2017 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.28 | 125,000 | 35,000 | 125,000 | |
Sep 06 2017 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | A | 0.28 | 125,000 | 35,000 | 125,000 | |
Sep 06 2017 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | A | 0.28 | 125,000 | 35,000 | 125,000 | |
Sep 06 2017 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.28 | 150,000 | 42,000 | 150,000 | |
Feb 06 2017 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Gift | G | 0.00 | 125,000 | 0 | 681,743 | 806.7 K to 681.7 K (-15.49 %) |
Jul 15 2016 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Gift | G | 0.00 | 65,000 | 0 | 806,743 | 871.7 K to 806.7 K (-7.46 %) |
Jul 15 2016 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Gift | G | 0.00 | 65,000 | 0 | 806,743 | 871.7 K to 806.7 K (-7.46 %) |
Jul 15 2016 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Gift | G | 0.00 | 60,000 | 0 | 871,743 | 931.7 K to 871.7 K (-6.44 %) |
Jul 15 2016 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Gift | G | 0.00 | 60,000 | 0 | 871,743 | 931.7 K to 871.7 K (-6.44 %) |
Mar 18 2016 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.64 | 100,000 | 64,000 | 100,000 | |
Mar 18 2016 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | A | 0.64 | 100,000 | 64,000 | 100,000 | |
Mar 18 2016 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | A | 0.64 | 100,000 | 64,000 | 100,000 | |
Mar 18 2016 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.64 | 200,000 | 128,000 | 200,000 | |
Mar 18 2016 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.64 | 200,000 | 128,000 | 200,000 | |
Jul 02 2015 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.36 | 250,000 | 90,000 | 250,000 | |
Jul 02 2015 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Gift | G | 0.00 | 125,000 | 0 | 931,743 | 1.1 M to 931.7 K (-11.83 %) |
Jul 02 2015 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.36 | 500,000 | 180,000 | 500,000 | |
Jul 02 2015 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | A | 0.36 | 100,000 | 36,000 | 100,000 | |
Jul 02 2015 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | A | 0.36 | 100,000 | 36,000 | 100,000 | |
Jul 02 2015 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.36 | 100,000 | 36,000 | 100,000 | |
Feb 13 2015 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.19 | 100,000 | 19,000 | 100,000 | |
Feb 13 2015 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.19 | 100,000 | 19,000 | 100,000 | |
Feb 13 2015 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | A | 0.19 | 100,000 | 19,000 | 100,000 | |
Feb 13 2015 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | A | 0.19 | 100,000 | 19,000 | 100,000 | |
Dec 29 2014 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Gift | G | 0.00 | 250,103 | 0 | 1,056,743 | 1.3 M to 1.1 M (-19.14 %) |
Sep 03 2014 | RGRX | REGENERX BIOPHARMA ... | G-treeBNT Co., Ltd. | 10% Owner | Option Exercise | X | 0.12 | 8,333,333 | 1,000,000 | 0 | |
Sep 03 2014 | RGRX | REGENERX BIOPHARMA ... | G-treeBNT Co., Ltd. | 10% Owner | Buy | X | 0.12 | 8,333,333 | 1,000,000 | 19,583,333 | 11.3 M to 19.6 M (+74.07 %) |
Apr 01 2014 | RGRX | REGENERX BIOPHARMA ... | Digital Aria Co., Ltd. | 10% Owner | Option Exercise | X | 0.12 | 11,250,000 | 1,350,000 | 0 | |
Apr 01 2014 | RGRX | REGENERX BIOPHARMA ... | Digital Aria Co., Ltd. | 10% Owner | Buy | X | 0.12 | 11,250,000 | 1,350,000 | 11,250,000 | 0 to 11.3 M |
Apr 01 2014 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.21 | 120,000 | 25,200 | 120,000 | |
Apr 01 2014 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.21 | 450,000 | 94,500 | 450,000 | |
Apr 01 2014 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.21 | 500,000 | 105,000 | 500,000 | |
Apr 01 2014 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | A | 0.21 | 120,000 | 25,200 | 120,000 | |
Apr 01 2014 | RGRX | REGENERX BIOPHARMA ... | Bowles L Thompson | Director | Option Exercise | A | 0.21 | 60,000 | 12,600 | 60,000 | |
Apr 01 2014 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | A | 0.21 | 150,000 | 31,500 | 150,000 | |
Oct 23 2012 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.15 | 46,666 | 7,000 | 46,666 | |
Oct 23 2012 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.15 | 66,667 | 10,000 | 66,667 | |
Oct 23 2012 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.15 | 20,000 | 3,000 | 20,000 | |
Oct 23 2012 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | J | 0.15 | 1 | 0 | 1 | |
Oct 23 2012 | RGRX | REGENERX BIOPHARMA ... | CAVAZZA PAOLO | 10% Owner | Option Exercise | J | 0.15 | 1 | 0 | 1 | |
Apr 05 2012 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.16 | 50,000 | 8,000 | 50,000 | |
Apr 05 2012 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.16 | 35,000 | 5,600 | 35,000 | |
Apr 05 2012 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.16 | 35,000 | 5,600 | 35,000 | |
Apr 05 2012 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | A | 0.16 | 50,000 | 8,000 | 50,000 | |
Apr 05 2012 | RGRX | REGENERX BIOPHARMA ... | CROCKFORD DAVID | VP of Clinical & Re ... | Option Exercise | A | 0.16 | 35,000 | 5,600 | 35,000 | |
Apr 05 2012 | RGRX | REGENERX BIOPHARMA ... | Bowles L Thompson | Director | Option Exercise | A | 0.16 | 50,000 | 8,000 | 50,000 | |
Apr 05 2012 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | A | 0.16 | 50,000 | 8,000 | 50,000 | |
Jan 26 2012 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.14 | 500,000 | 70,000 | 500,000 | |
Jan 26 2012 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.14 | 300,000 | 42,000 | 300,000 | |
Dec 06 2011 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.16 | 80,135 | 12,822 | 80,135 | |
Dec 06 2011 | RGRX | REGENERX BIOPHARMA ... | CROCKFORD DAVID | VP of Clinical & Re ... | Option Exercise | A | 0.16 | 91,991 | 14,719 | 91,991 | |
Dec 06 2011 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.16 | 80,135 | 12,822 | 80,135 | |
Aug 05 2011 | RGRX | REGENERX BIOPHARMA ... | Bowles L Thompson | Director | Option Exercise | A | 0.22 | 20,000 | 4,400 | 20,000 | |
Aug 05 2011 | RGRX | REGENERX BIOPHARMA ... | MCNAY JOSEPH C | Director | Option Exercise | A | 0.22 | 20,000 | 4,400 | 20,000 | |
Aug 05 2011 | RGRX | REGENERX BIOPHARMA ... | Bove Mauro | Director | Option Exercise | A | 0.22 | 20,000 | 4,400 | 20,000 | |
Aug 05 2011 | RGRX | REGENERX BIOPHARMA ... | CROCKFORD DAVID | VP of Clinical & Re ... | Option Exercise | A | 0.22 | 98,500 | 21,670 | 98,500 | |
Aug 05 2011 | RGRX | REGENERX BIOPHARMA ... | GOLDSTEIN ALLAN L | Director | Option Exercise | A | 0.22 | 98,500 | 21,670 | 98,500 | |
Aug 05 2011 | RGRX | REGENERX BIOPHARMA ... | Elsey R Don | Director | Option Exercise | A | 0.22 | 20,000 | 4,400 | 20,000 | |
Aug 05 2011 | RGRX | REGENERX BIOPHARMA ... | FINKELSTEIN J J | President and CEO | Option Exercise | A | 0.22 | 125,000 | 27,500 | 125,000 | |
Jan 07 2011 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | J | 0.38 | 1 | 0 | 4 | |
Jan 07 2011 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | J | 1.74 | 1 | 2 | 0 | |
Jan 07 2011 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | J | 0.38 | 1 | 0 | 3 | |
Jan 07 2011 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | J | 1.60 | 1 | 2 | 0 | |
Jan 07 2011 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | J | 0.38 | 1 | 0 | 2 | |
Jan 07 2011 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | J | 2.75 | 1 | 3 | 0 | |
Jan 07 2011 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | J | 0.38 | 1 | 0 | 1 | |
Jan 07 2011 | RGRX | REGENERX BIOPHARMA ... | Sinaf S.A. | 10% Owner | Option Exercise | J | 4.06 | 1 | 4 | 0 |